Journal of Applied Physiology http://www.adinstruments.com/labchart/faseb
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


J Appl Physiol (May 3, 2007). doi:10.1152/japplphysiol.00139.2007
This Article
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
103/1/190    most recent
00139.2007v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'Leary, D. S
Right arrow Articles by Ichinose, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'Leary, D. S
Right arrow Articles by Ichinose, M.
Submitted on February 1, 2007
Accepted on April 25, 2007

Muscle metaboreflex induced increases in cardiac sympathetic activity vasoconstrict the coronary vasculature

Donal S O'Leary1*, Javier A Sala-Mercado1, Robert L Hammond2, Eric J. Ansorge1, Jong-Kyung Kim3, Jaime Rodriguez3, Dominic Fano4, and Masashi Ichinose4

1 Department of Physiology, Wayne State University, Detroit, Michigan, United States
2 Surgery, Wayne State University, Detroit, Michigan, United States
3 Physiology, Wayne State University, Michigan, United States
4 Physiology, Wayne State University, 48201, Michigan, United States

* To whom correspondence should be addressed. E-mail: doleary{at}med.wayne.edu.

Ischemia of active skeletal muscle evokes a powerful blood pressure raising reflex termed the muscle metaboreflex (MMR). MMR activation increases cardiac sympathetic nerve activity which increases heart rate, ventricular contractility and cardiac output (CO). However, despite the marked increase in ventricular work, no coronary vasodilation occurs. Using conscious, chronically instrumented dogs, we observed MMR induced changes in arterial pressure, CO, left circumflex coronary blood flow (CBF) and coronary vascular conductance (CVC) before and after alpha 1 receptor blockade (prazosin, 100µg/kg, i.v.). MMR was activated during mild treadmill exercise by partially reducing hindlimb blood flow. In control experiments MMR activation caused a substantial pressor response mediated via increases in CO. Although CBF increased (+28.1 ± 3.7 ml/min, P < 0.05), CVC did not change ( 0.45 ± 0.05 vs. 0.47 ± 0.06 ml/min/mmHg, P > 0.05, exercise vs. exercise with MMR activation, respectively). Thus all of the increase in CBF was due to the increase in arterial pressure. In contrast, after prazosin, MMR activation caused a greater increase in CBF (+55.9 ± 17.1 ml/min P < 0.05 vs. control) and CVC rose significantly (0.59 ± 0.08 vs. 0.81 ± 0.17 ml/min/mmHg, P < 0.05, exercise vs. exercise with MMR activation, respectively). A greater increase in CO also occurred (+2.01 ± 0.1 vs. +3.27 ± 1.1 l/min, P < 0.05 control vs. prazosin, respectively) . We conclude that the MMR induced increases in sympathetic activity to the heart functionally restrain coronary vasodilation which may limit increases in ventricular function.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1948 by the American Physiological Society.